Rezultati - Mohammad Ismail Hossain

MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial od Mrinal M. Gounder, Melissa L. Johnson, Rebecca S. Heist, Geoffrey I. Shapiro, Sophie Postel‐Vinay, Frederick H. Wilson, Elena Garralda, Gerburg M. Wulf, Caroline Almon, Salah Nabhan, Elia Aguado-Fraile, Peng He, Mathilde Romagnoli, Mohammad Ismail Hossain, Rohini Narayanaswamy, Amel Sadou-Dubourgnoux, Michael K. Cooper, Vasileios Askoxylakis, Howard A. Burris, Josep Tabernero